Results 91 to 100 of about 21,232 (243)

IMGT/mAb-KG: the knowledge graph for therapeutic monoclonal antibodies

open access: yesFrontiers in Immunology
IntroductionTherapeutic monoclonal antibodies (mAbs) have demonstrated promising outcomes in diverse clinical indications, including but not limited to graft rejection, cancer, and autoimmune diseases lately.Recognizing the crucial need for the ...
Gaoussou Sanou   +6 more
doaj   +1 more source

MHC (RT1) and CD45 (RT7) immunogenetics of strain combinations used for the bone marrow transplantation model.

open access: yes, 2016
MHC (RT1) and CD45 (RT7) immunogenetics of strain combinations used for the bone marrow transplantation model.
Hüseyin Bektas (562057)   +7 more
core   +1 more source

Iptacopan monotherapy resulted in increased hemoglobin level in patients with PNH and hemoglobin ≥10 g/dL after anti‐C5 therapy

open access: yesHemaSphere, Volume 10, Issue 6, June 2026.
Abstract Patients with paroxysmal nocturnal hemoglobinuria (PNH) on anti‐C5 often experience extravascular hemolysis with anemia. Iptacopan, the first oral proximal complement inhibitor targeting factor B, has shown efficacy and safety in PNH patients. APPULSE‐PNH (NCT05630001), a phase 3b, single‑arm, open‐label trial, enrolled adult patients with PNH
Austin Kulasekararaj   +31 more
wiley   +1 more source

Access to diagnosis using liquid biopsy (ADLiB): Identifying lymphoma in a tuberculosis‐endemic setting

open access: yesHemaSphere, Volume 10, Issue 6, June 2026.
Abstract In HIV‐ and tuberculosis (TB)‐endemic regions, lymphoma diagnosis is often delayed because symptoms can overlap with TB, and access to biopsy and specialized pathology is limited. To address this, we developed and internally evaluated the Access to Diagnosis using Liquid Biopsy (ADLiB) platform—a plasma cell‐free DNA (cfDNA)‐based approach ...
Katherine Antel   +21 more
wiley   +1 more source

IMMUNOGENETICS OF RABBIT LOW-DENSITY LIPOPROTEINS.

open access: yes, 1969
IMMUNOGENETICS OF RABBIT LOW-DENSITY ...
JOHN JOSEPH. ALBERS (7974092)
core  

IMGT-Choreography for immunogenetics and immunoinformatics.

open access: yes, 2005
International audienceIMGT, the international ImMunoGeneTics information system (http://imgt.cines.fr), was created in 1989 at Montpellier, France. IMGT is a high quality integrated knowledge resource specialized in immunoglobulins (IG), T cell receptors
Combres, Kora   +10 more
core   +1 more source

FAIRness and Immunogenetics

open access: yes, 2020
For many decades, the immunogenetics community has been among the frontrunners in sharing data and samples, ensuring a great scientific progress in this domain. International histocompatibility workshops and scientific meetings in immunogenetics societies as EFI and ASHI have largely contributed to this progress.
Thomsen, Mogens   +3 more
openaire   +2 more sources

IMGT, the international ImMunoGeneTics database

open access: yes, 1999
IMGT, the international ImMunoGeneTics database (http://imgt.cnusc.fr:8104), is a high-quality integrated database specialising in Immunoglobulins (Ig), T cell Receptors (TcR) and Major Histocompatibility Complex (MHC) molecules of all vertebrate species,
Chaume, Denys   +11 more
core   +1 more source

Cold Agglutinin Disease–Like Genetic Signatures in Lymphoplasmacytic Lymphoma–Like Cases Challenge the WHO Fifth Edition Classification

open access: yeseJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Background The fifth edition of the World Health Organization (WHO) classification defines cold agglutinin disease (CAD) as a clonal B‐cell lymphoproliferative disorder occurring in the absence of overt lymphoma, whereas cases associated with lymphoma are classified as cold agglutinin syndrome (CAS).
Yuki Sato   +7 more
wiley   +1 more source

From Data to Decisions: How Machine Learning and Generative Artificial Intelligence Are Redefining Precision Medicine in Kidney Transplantation

open access: yesOrgan Medicine, Volume 3, Issue 2, Page 102-118, June 2026.
This review evaluates how machine learning, multimodal integration, and generative AI optimize kidney transplant outcomes. These tools enable superior prediction and personalized therapy but face hurdles in data volume, generalizability, and ethics. Future clinical adoption depends on continued innovation and multidisciplinary collaboration to overcome
Maoxin Liao, Cheng Yang
wiley   +1 more source

Home - About - Disclaimer - Privacy